FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135334015> ?p ?o ?g. }

• W2135334015 endingPage "256" @default.
• W2135334015 startingPage "250" @default.
• W2135334015 abstract "Study objective We investigate the incidence of adverse events at 1 year in the cohort of emergency department (ED) syncope patients enrolled in the original Risk Stratification of Syncope in the Emergency Department (ROSE) study, the time to adverse event, and the test performance of the ROSE decision instrument to detect events at 1 year. Methods This report details the 1-year follow-up of adult syncope patients presenting to the ED who were enrolled into the ROSE study, a single-center, prospective, observational cohort study. The primary endpoint was the combination of serious outcome and all-cause death at 1 year. Serious outcome encompassed acute myocardial infarction, life-threatening arrhythmia, need for pacemaker/implantable defibrillator, pulmonary embolus, cerebrovascular accident, intracranial or subarachnoid hemorrhage, and interventional procedure or hemorrhage requiring blood transfusion. Secondary endpoints were all-cause death and cardiovascular serious outcome at 1 year. Results One thousand forty-three patients were available for analysis; 162 patients (15.5%) had a primary outcome. Twenty-eight (17%) of these were within 24 hours, 56 (35%) were within 1 week, and 78 (48%) were within 1 month. The remaining 84 (52%) outcomes occurred between months 2 and 12. At 1 year, 71 (6.8%) patients had died and 76 (7.3%) had a cardiovascular serious outcome. The sensitivity and specificity of the ROSE decision instrument for 1-year serious outcome and all-cause death were, respectively, 71.6% (95% confidence interval [CI] 63.9% to 78.3%) and 71.1% (95% CI 67.9% to 74.0%); for 1-year all-cause death, 76.1% (95% CI 64.2% to 85.1%) and 67.4% (95% CI 64.3% to 70.3%); and for 1-year cardiovascular serious outcome, 75.0% (95% CI 63.5% to 83.9%) and 67.5% (95% CI 64.5% to 70.5%). Conclusion The proportion of patients with serious outcome and all-cause death 1 year after syncope is similar to that reported in recent international syncope studies. We have defined the proportion of patients with cardiovascular serious outcome at 1 year and have shown that most events occurred in the first month, with decreased frequency of events observed after that time especially marked for cardiovascular serious outcome. More than 50% of the outcomes observed, however, occurred after the first month. The ROSE decision instrument does not perform well at predicting 1-year outcome of ED syncope patients. We investigate the incidence of adverse events at 1 year in the cohort of emergency department (ED) syncope patients enrolled in the original Risk Stratification of Syncope in the Emergency Department (ROSE) study, the time to adverse event, and the test performance of the ROSE decision instrument to detect events at 1 year. This report details the 1-year follow-up of adult syncope patients presenting to the ED who were enrolled into the ROSE study, a single-center, prospective, observational cohort study. The primary endpoint was the combination of serious outcome and all-cause death at 1 year. Serious outcome encompassed acute myocardial infarction, life-threatening arrhythmia, need for pacemaker/implantable defibrillator, pulmonary embolus, cerebrovascular accident, intracranial or subarachnoid hemorrhage, and interventional procedure or hemorrhage requiring blood transfusion. Secondary endpoints were all-cause death and cardiovascular serious outcome at 1 year. One thousand forty-three patients were available for analysis; 162 patients (15.5%) had a primary outcome. Twenty-eight (17%) of these were within 24 hours, 56 (35%) were within 1 week, and 78 (48%) were within 1 month. The remaining 84 (52%) outcomes occurred between months 2 and 12. At 1 year, 71 (6.8%) patients had died and 76 (7.3%) had a cardiovascular serious outcome. The sensitivity and specificity of the ROSE decision instrument for 1-year serious outcome and all-cause death were, respectively, 71.6% (95% confidence interval [CI] 63.9% to 78.3%) and 71.1% (95% CI 67.9% to 74.0%); for 1-year all-cause death, 76.1% (95% CI 64.2% to 85.1%) and 67.4% (95% CI 64.3% to 70.3%); and for 1-year cardiovascular serious outcome, 75.0% (95% CI 63.5% to 83.9%) and 67.5% (95% CI 64.5% to 70.5%). The proportion of patients with serious outcome and all-cause death 1 year after syncope is similar to that reported in recent international syncope studies. We have defined the proportion of patients with cardiovascular serious outcome at 1 year and have shown that most events occurred in the first month, with decreased frequency of events observed after that time especially marked for cardiovascular serious outcome. More than 50% of the outcomes observed, however, occurred after the first month. The ROSE decision instrument does not perform well at predicting 1-year outcome of ED syncope patients." @default.
• W2135334015 created "2016-06-24" @default.
• W2135334015 creator A5004488025 @default.
• W2135334015 creator A5024577360 @default.
• W2135334015 creator A5058558191 @default.
• W2135334015 creator A5074252129 @default.
• W2135334015 date "2011-09-01" @default.
• W2135334015 modified "2023-09-26" @default.
• W2135334015 title "One-Year Prognosis After Syncope and the Failure of the ROSE Decision Instrument to Predict One-Year Adverse Events" @default.
• W2135334015 cites W1553345686 @default.
• W2135334015 cites W1998966286 @default.
• W2135334015 cites W2060847368 @default.
• W2135334015 cites W2092319060 @default.
• W2135334015 cites W2131370832 @default.
• W2135334015 cites W2131763560 @default.
• W2135334015 cites W2169409503 @default.
• W2135334015 cites W2169690274 @default.
• W2135334015 cites W2338589661 @default.
• W2135334015 doi "https://doi.org/10.1016/j.annemergmed.2010.12.021" @default.
• W2135334015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21288597" @default.
• W2135334015 hasPublicationYear "2011" @default.
• W2135334015 type Work @default.
• W2135334015 sameAs 2135334015 @default.
• W2135334015 citedByCount "26" @default.
• W2135334015 countsByYear W21353340152012 @default.
• W2135334015 countsByYear W21353340152013 @default.
• W2135334015 countsByYear W21353340152014 @default.
• W2135334015 countsByYear W21353340152015 @default.
• W2135334015 countsByYear W21353340152016 @default.
• W2135334015 countsByYear W21353340152018 @default.
• W2135334015 countsByYear W21353340152019 @default.
• W2135334015 countsByYear W21353340152020 @default.
• W2135334015 countsByYear W21353340152021 @default.
• W2135334015 countsByYear W21353340152023 @default.
• W2135334015 crossrefType "journal-article" @default.
• W2135334015 hasAuthorship W2135334015A5004488025 @default.
• W2135334015 hasAuthorship W2135334015A5024577360 @default.
• W2135334015 hasAuthorship W2135334015A5058558191 @default.
• W2135334015 hasAuthorship W2135334015A5074252129 @default.
• W2135334015 hasConcept C118552586 @default.
• W2135334015 hasConcept C126322002 @default.
• W2135334015 hasConcept C188816634 @default.
• W2135334015 hasConcept C194828623 @default.
• W2135334015 hasConcept C197934379 @default.
• W2135334015 hasConcept C203092338 @default.
• W2135334015 hasConcept C2777736543 @default.
• W2135334015 hasConcept C2780724011 @default.
• W2135334015 hasConcept C500558357 @default.
• W2135334015 hasConcept C535046627 @default.
• W2135334015 hasConcept C71924100 @default.
• W2135334015 hasConcept C72563966 @default.
• W2135334015 hasConceptScore W2135334015C118552586 @default.
• W2135334015 hasConceptScore W2135334015C126322002 @default.
• W2135334015 hasConceptScore W2135334015C188816634 @default.
• W2135334015 hasConceptScore W2135334015C194828623 @default.
• W2135334015 hasConceptScore W2135334015C197934379 @default.
• W2135334015 hasConceptScore W2135334015C203092338 @default.
• W2135334015 hasConceptScore W2135334015C2777736543 @default.
• W2135334015 hasConceptScore W2135334015C2780724011 @default.
• W2135334015 hasConceptScore W2135334015C500558357 @default.
• W2135334015 hasConceptScore W2135334015C535046627 @default.
• W2135334015 hasConceptScore W2135334015C71924100 @default.
• W2135334015 hasConceptScore W2135334015C72563966 @default.
• W2135334015 hasIssue "3" @default.
• W2135334015 hasLocation W21353340151 @default.
• W2135334015 hasLocation W21353340152 @default.
• W2135334015 hasOpenAccess W2135334015 @default.
• W2135334015 hasPrimaryLocation W21353340151 @default.
• W2135334015 hasRelatedWork W1990717801 @default.
• W2135334015 hasRelatedWork W2026095104 @default.
• W2135334015 hasRelatedWork W2042623737 @default.
• W2135334015 hasRelatedWork W2061619006 @default.
• W2135334015 hasRelatedWork W2140173513 @default.
• W2135334015 hasRelatedWork W2156971356 @default.
• W2135334015 hasRelatedWork W2381224018 @default.
• W2135334015 hasRelatedWork W2510700473 @default.
• W2135334015 hasRelatedWork W2613637409 @default.
• W2135334015 hasRelatedWork W4232888950 @default.
• W2135334015 hasVolume "58" @default.
• W2135334015 isParatext "false" @default.
• W2135334015 isRetracted "false" @default.
• W2135334015 magId "2135334015" @default.
• W2135334015 workType "article" @default.